This feature was first published in the Evening Telegraph on 22 October 2024.
I was delighted to hear the news about Dundee leading a new Parkinson’s research initiative in collaboration with the Michael J. Fox Foundation.
This is not just a big moment for our university; it’s a crucial step forward in the fight against neurodegenerative diseases, especially focusing on LRRK2, the most common genetic cause of inherited Parkinson’s disease.
Back in July, I looked at the heavy burden of Parkinson’s disease on individuals and families, highlighting the profound impact it has on daily life.
At that time, I celebrated the groundbreaking work being done at the University of Dundee, including the recent success of Scotland’s first ultrasound thalamotomy, which gave renewed hope to patients like Ian Keir.
This new initiative builds on that momentum and could truly be a game changer.
With funding in the tens of millions of pounds, it highlights how important it is to turn scientific discoveries into real treatments.
It's an exciting time for Dundee, as we position ourselves as a beacon of hope for those affected by Parkinson’s.
At the heart of this initiative is Professor Dario Alessi, a leading expert in kinase research.
His work has already made a significant impact in the field, and his leadership will be vital as we move forward. The Division of Signal Transduction Therapy, which he heads, is a great example of how academia and the pharmaceutical industry can work together to ensure research benefits patients directly.
This announcement means a lot to our local community. It’s not just about scientific progress; it’s about improving the lives of countless individuals and families facing Parkinson’s.
Dundee has always been known for its strong sense of community, and this initiative strengthens that spirit.
We are seeing cutting-edge research combined with compassionate care, paving the way for a future where Parkinson’s may not be as debilitating as it once was.
The collaboration with the Michael J. Fox Foundation adds to the momentum. The Foundation has a rich history of advocating for Parkinson’s research and patient care, and their involvement shows we are in this together.
This partnership signifies a shared goal: to tackle the challenges of this complex disease with a multi-faceted approach.
What’s more, this initiative has the potential to build a culture of innovation and hope within Dundee.
I take immense pride in this announcement for Dundee. It reinforces our reputation as a leader in pioneering research and shows our commitment to addressing one of the major health challenges of our time.
I am excited to see how this initiative unfolds and what breakthroughs will emerge from the University of Dundee.
Together, we are on the brink of significant advancements that could change the landscape of Parkinson’s treatment and improve the quality of life for many.
The path to a brighter future for those affected by Parkinson’s is clearer than ever, thanks to the remarkable work happening in our city.
Comments